How THC and CBD Work Differently in the Brain and Why It Matters
A pharmacology review explained how CBD can reduce some of THC's psychoactive effects, leading to the development of Nabiximols, a THC/CBD combination drug for MS spasticity.
Quick Facts
What This Study Found
This review examined the pharmacodynamic interplay between THC and CBD, the two most studied of the 70+ phytocannabinoids in cannabis.
THC directly activates CB1 and CB2 cannabinoid receptors, producing its well-known psychoactive effects. CBD, by contrast, has very low affinity for these receptors and works through other mechanisms. Evidence suggests CBD can decrease some of the psychomimetic (psychosis-like) effects of THC.
This opposing relationship between THC and CBD led to the development of Nabiximols (Sativex), a pharmaceutical spray containing a roughly 1:1 ratio of THC to CBD, approved for moderate to severe spasticity in multiple sclerosis.
Key Numbers
Cannabis contains more than 70 phytocannabinoids. THC and CBD are the two most studied. Nabiximols contains a roughly 1:1 THC:CBD ratio.
How They Did This
This was a pharmacodynamic review published in The Mental Health Clinician, examining the evidence for how THC and CBD interact at the receptor and cellular level.
Why This Research Matters
Understanding that THC and CBD have opposing effects helps explain why different cannabis strains and products produce different experiences. It also has practical implications for medical cannabis formulation and for understanding why high-THC, low-CBD products may carry greater risk.
The Bigger Picture
The THC-CBD interaction has become one of the most important concepts in cannabis science. As the cannabis market has evolved toward increasingly high-THC products with minimal CBD, this review's emphasis on CBD's moderating role has become even more relevant.
What This Study Doesn't Tell Us
The abstract provided limited mechanistic detail. The evidence for CBD reducing THC's effects comes from specific experimental paradigms and may not apply uniformly to all of THC's actions. The optimal ratio of THC to CBD for therapeutic purposes remains unclear.
Questions This Raises
- ?What is the optimal THC:CBD ratio for different medical conditions?
- ?Does CBD meaningfully reduce THC's adverse effects when both are consumed together in recreational cannabis?
Trust & Context
- Key Stat:
- CBD can decrease some of THC's psychosis-like effects
- Evidence Grade:
- This is a pharmacodynamic review synthesizing evidence on THC-CBD interactions. It provides moderate-quality mechanistic overview.
- Study Age:
- Published in 2016. Understanding of THC-CBD interactions has continued to develop, particularly with the growing CBD product market.
- Original Title:
- Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the "weed," a pharmacodynamic discussion.
- Published In:
- The mental health clinician, 6(6), 277-284 (2016)
- Database ID:
- RTHC-01108
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Does CBD cancel out THC's effects?
CBD appears to reduce some of THC's psychomimetic effects but does not completely block THC. The interaction is more nuanced than simple cancellation, and CBD has its own pharmacological actions independent of its relationship to THC.
Why does the THC:CBD ratio matter?
Different ratios produce different overall effects. Products with high THC and little CBD may produce stronger psychoactive effects and potentially more adverse reactions, while balanced THC:CBD products like Nabiximols may offer therapeutic benefits with fewer side effects.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-01108APA
Boggs, Douglas Lee; Peckham, Alyssa; Boggs, Angela A; Ranganathan, Mohini. (2016). Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the "weed," a pharmacodynamic discussion.. The mental health clinician, 6(6), 277-284. https://doi.org/10.9740/mhc.2016.11.277
MLA
Boggs, Douglas Lee, et al. "Delta-9-tetrahydrocannabinol and cannabidiol: Separating the chemicals from the "weed," a pharmacodynamic discussion.." The mental health clinician, 2016. https://doi.org/10.9740/mhc.2016.11.277
RethinkTHC
RethinkTHC Research Database. "Delta-9-tetrahydrocannabinol and cannabidiol: Separating the..." RTHC-01108. Retrieved from https://rethinkthc.com/research/boggs-2016-delta9tetrahydrocannabinol-and-cannabidiol-separating
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.